Angel News

Angel News

Back to Homepage

12th February 2018

LIfT BioSciences hits target with Shadow Foundr

LIfT BioSciences has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage